This report contains market size and forecasts of Cancer Spit Test Device in global, including the following market information:
- Global Cancer Spit Test Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Cancer Spit Test Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cancer Spit Test Device companies in 2021 (%)
The global Cancer Spit Test Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Passive Drool Collection Methods Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Spit Test Device include Biocartis Group, BD, Abbott Laboratories, Roche Holding AG, Qiagen, Agilent Technologies, BioMerieux, Canvax and Color Health Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Spit Test Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Spit Test Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Spit Test Device Market Segment Percentages, by Type, 2021 (%)
- Passive Drool Collection Methods
- Oral Swab Collection Methods
Global Cancer Spit Test Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Spit Test Device Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Diagnostic Laboratories
- Oncology Speciality Clinics
- Cancer Research Institutes
- Others
Global Cancer Spit Test Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Spit Test Device Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer Spit Test Device revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Cancer Spit Test Device revenues share in global market, 2021 (%)
- Key companies Cancer Spit Test Device sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Cancer Spit Test Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Biocartis Group
- BD
- Abbott Laboratories
- Roche Holding AG
- Qiagen
- Agilent Technologies
- BioMerieux
- Canvax
- Color Health Inc
- DNA Genotek Inc.
- Illumina
- Miraclean Technology Co.,Ltd.
- Oasis Diagnostics Corporation
- PeriRx
- Salimetrics
- Sarstedt
- Siemens Healthineers
- Thermo Fisher Scientific
